BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34544766)

  • 1. Lung Cancer Screening Eligibility and Use: A Population Health Perspective of One Community.
    Tailor TD; Farrow NE; Gao J; Choudhury KR; Tong BC
    N C Med J; 2021; 82(5):321-326. PubMed ID: 34544766
    [No Abstract]   [Full Text] [Related]  

  • 2. Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population.
    Tailor TD; Tong BC; Gao J; Henderson LM; Choudhury KR; Rubin GD
    Chest; 2020 Nov; 158(5):2200-2210. PubMed ID: 32562612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
    Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
    Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
    Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
    JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
    Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
    Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
    Li J; Chung S; Wei EK; Luft HS
    BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer screening eligibility and use with low-dose computed tomography: Results from the 2018 Behavioral Risk Factor Surveillance System cross-sectional survey.
    Narayan AK; Gupta Y; Little BP; Shepard JO; Flores EJ
    Cancer; 2021 Mar; 127(5):748-756. PubMed ID: 33206388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented meaningful use criteria to identify patients eligible for lung cancer screening.
    Raz DJ; Dunham R; Tiep B; Sandoval A; Grannis F; Rotter A; Kim JY
    Ann Thorac Surg; 2014 Sep; 98(3):996-1002. PubMed ID: 25063304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Cancer Screening Eligibility and Utilization Among Transgender Patients: An Analysis of the 2017-2018 United States Behavioral Risk Factor Surveillance System Survey.
    Stowell JT; Parikh Y; Tilson K; Narayan AK
    Nicotine Tob Res; 2020 Dec; 22(12):2164-2169. PubMed ID: 32623455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with low-dose CT lung cancer screening participation in a high burden state: Results from the 2017-2018 BRFSS.
    Sedani AE; Ford LA; James SA; Beebe LA
    J Cancer Policy; 2021 Jun; 28():100284. PubMed ID: 35559913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals.
    Gudina AT; Kamen C; Hardy SJ; Kehoe L; Culakova E; Cupertino AP
    Lung Cancer; 2024 May; 191():107539. PubMed ID: 38552545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study.
    Silvestri GA; Goldman L; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Tanner NT; Fedewa S
    Ann Intern Med; 2022 Nov; 175(11):1501-1505. PubMed ID: 36215712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with adherence to provider referrals for lung cancer screening with low dose computed tomography before and during COVID-19 pandemic.
    Li J; Stults CD; Liang SY; Martinez M
    BMC Cancer; 2023 Aug; 23(1):809. PubMed ID: 37644406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019.
    Advani S; Zhang D; Tammemagi M; Akinyemiju T; Gould MK; Silvestri GA; Braithwaite D
    Ann Am Thorac Soc; 2021 Nov; 18(11):1886-1893. PubMed ID: 33939595
    [No Abstract]   [Full Text] [Related]  

  • 15. Geographic Access to CT for Lung Cancer Screening: A Census Tract-Level Analysis of Cigarette Smoking in the United States and Driving Distance to a CT Facility.
    Tailor TD; Choudhury KR; Tong BC; Christensen JD; Sosa JA; Rubin GD
    J Am Coll Radiol; 2019 Jan; 16(1):15-23. PubMed ID: 30181089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography.
    Raz DJ; Wu GX; Consunji M; Nelson RA; Kim H; Sun CL; Sun V; Kim JY
    Clin Lung Cancer; 2018 Jan; 19(1):51-57. PubMed ID: 28652090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
    Su CT; Bhargava A; Shah CD; Halmos B; Gucalp RA; Packer SH; Ohri N; Haramati LB; Perez-Soler R; Cheng H
    Clin Lung Cancer; 2018 Sep; 19(5):e767-e773. PubMed ID: 29937386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating Eligibility for Lung Cancer Screening by Neighborhood in Philadelphia Using Previous and Current USPSTF Guidelines.
    McIntire RK; Lewis E; Zeigler-Johnson C; Shusted C; Barta J; Juon HS; Keith SW; Klein G
    Popul Health Manag; 2022 Apr; 25(2):254-263. PubMed ID: 35442796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
    Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
    JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Provider Lung Cancer Screening Discussions: An Analysis of a National Survey.
    Nourmohammadi N; Liang THP; Sadigh G
    Clin Lung Cancer; 2024 Jun; 25(4):e189-e195.e2. PubMed ID: 38522980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.